Alphatec Holdings Inc ATEC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ATEC to Spotlight Clinically Integrated Informatics at NASS 2024
-
ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance
-
ATEC to Present at Upcoming Conferences
-
ATEC Launches EOS InsightTM, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI
-
ATEC to Report Second Quarter Financial Results on July 31, 2024
Trading Information
- Previous Close Price
- $5.26
- Day Range
- $5.23–5.23
- 52-Week Range
- $5.08–17.32
- Bid/Ask
- $5.23 / $5.34
- Market Cap
- $733.90 Mil
- Volume/Avg
- 361 / 2.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 839
- Website
- https://www.atecspine.com
Comparables
Valuation
|
Metric
|
ATEC
|
SIBN
|
ANIK
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 80.71 |
Price/Book Value | 43.32 | 3.43 | 1.77 |
Price/Sales | 1.31 | 3.68 | 2.20 |
Price/Cash Flow | — | — | 18.11 |
Price/Earnings
ATEC
SIBN
ANIK
Financial Strength
|
Metric
|
ATEC
|
SIBN
|
ANIK
|
|---|---|---|---|
Quick Ratio | 1.08 | 7.99 | 3.70 |
Current Ratio | 2.22 | 9.17 | 5.93 |
Interest Coverage | −8.06 | −12.97 | — |
Quick Ratio
ATEC
SIBN
ANIK
Profitability
|
Metric
|
ATEC
|
SIBN
|
ANIK
|
|---|---|---|---|
Return on Assets (Normalized) | −9.32% | −6.03% | 2.40% |
Return on Equity (Normalized) | −562.13% | −8.10% | 2.97% |
Return on Invested Capital (Normalized) | −8.81% | −8.97% | 1.92% |
Return on Assets
ATEC
SIBN
ANIK
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Swwrmdh | Wrdbns | $197.7 Bil | |||
| Stryker Corp
SYK
| Kjbqzwwwng | Dlydc | $135.3 Bil | |||
| Boston Scientific Corp
BSX
| Dbbwgqvmw | Wyygwlg | $124.4 Bil | |||
| Medtronic PLC
MDT
| Yzchbzk | Fyfxwp | $114.3 Bil | |||
| Edwards Lifesciences Corp
EW
| Mcgmycglr | Zcfgxhm | $39.2 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Qfwsj | Hrg | $30.2 Bil | |||
| DexCom Inc
DXCM
| Xybmjjtqf | Sqyx | $26.9 Bil | |||
| Steris PLC
STE
| Kncnpfzn | Qddcm | $23.1 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Vpmcgkgkc | Wphtk | $21.5 Bil | |||
| Insulet Corp
PODD
| Jwltrwgtl | Bfklhmw | $16.3 Bil |
United States